Lilly Says Zepbound Provided 47% Higher Relative Weight Loss Compared To Wegovy In SURMOUNT-5 Study
4/12 14:04
(RTTNews) - Eli Lilly and Company (LLY) Wednesday announced encouraging topline results from the SURMOUNT-5 phase 3b study of Zepbound in adults with obesity....